Synthetic Biologics, Inc. (SYN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Synthetic Biologics, Inc. (SYN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Synthetic Biologics, Inc. (SYN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Synthetic Biologics, Inc. (SYN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
43 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Synthetic Biologics, Inc. (Synthetic Biologics) formerly Adeona Pharmaceuticals, Inc. is a biotechnology company that develops therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The company develops SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention of C. Its products are used in the treatment of relapsing-remitting multiple sclerosis, cognitive dysfunction in multiple sclerosis, C. difficile infection prevention, pertussis, acinetobacter infection and irritable bowel syndrome.

Synthetic Biologics, Inc. (SYN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major r

  
Source:
Document ID
GDPH139210D
Country
Industry
Ticker
SYN=US
Company
Synthetic Biologics, Inc.
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Synthetic Biologics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Synthetic Biologics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Synthetic Biologics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Synthetic Biologics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Synthetic Biologics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Synthetic Biologics, Inc., Pharmaceuticals &Healthcare, Deal Details1128
  Asset Purchase111
    Synthetic Biologics Completes Acquisition Of C. difficile Infectious Disease Program Of Prev AbR112
  Partnerships131
    Intrexon Enters into Partnership with Synthetic Biologics131
    Synthetic Biologics Enters Into Agreement With Intrexon To Develop Monoclonal Antibodies For Infectious Diseases142
    Adeona Pharma Enters Into Co-Development Agreement With Intrexon162
    Adeona Pharma Enters Into Co-Development Agreement With Meda182
  Licensing Agreements201
    Synthetic Biologics Terminates Licensing Agreement with University of California202
    Synthetic Biologics Enters Into Licensing Agreement With Cedars-Sinai Medical Center222
  Equity Offering241
    Synthetic Biologics Raises USD46 Million in Public Offering of Shares242
    Synthetic Biologics to Raise USD20.7 Million in Private Placement of Units262
    Synthetic Biologics Completes Public Offering Of Shares For US$13.2 Million282
    Synthetic Biologics Completes Private Placement Of Common Stock For US$11 Million302
    Adeona Pharma Completes Private Placement Of Shares For US$3.5 Million322
    Adeona Pharma Completes Registered Direct Offering For US$4 Million342
    Adeona Pharma Completes Private Placement Of US$1 Million362
  Acquisition381
    Hartlab Acquires Adeona Clinical Lab From Synthetic Biologics381
Synthetic Biologics, Inc. - Key Competitors391
Key Employees401
Locations And Subsidiaries412
  Head Office411
  Other Locations &Subsidiaries412
Appendix431
  Methodology431
  About GlobalData431
  Contact Us431
  Disclaimer431

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Synthetic Biologics, Inc. (SYN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Synthetic-Biologics-Inc-SYN-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7758>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Synthetic Biologics, Inc. (SYN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Synthetic-Biologics-Inc-SYN-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7758>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research